Literature DB >> 9605577

Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function.

S Rotondo1, G Rajtar, S Manarini, A Celardo, D Rotillo, G de Gaetano, V Evangelista, C Cerletti.   

Abstract

1. Polymorphonuclear leukocytes (PMN) may contribute to the pathogenesis of acute coronary heart disease (CHD). 2. Epidemiological and laboratory evidence suggests that red wine, by virtue of its polyphenolic constituents, may be more effective than other alcoholic beverages in reducing the risk of CHD mortality. 3 The aim of the present study was to investigate the effects of trans-resveratrol (3,4',5-trihydroxy-trans-stilbene), a polyphenol present in most red wines, on functional and biochemical responses of PMN, upon in vitro activation. 4. trans-Resveratrol exerted a strong inhibitory effect on reactive oxygen species produced by PMN stimulated with 1 microM formyl methionyl leucyl phenylalamine (fMLP) (IC50 1.3+/-0.13 microM, mean+/-s.e.mean), as evaluated by luminol-amplified chemiluminescence. 5. trans-Resveratrol prevented the release of elastase and beta-glucuronidase by PMN stimulated with the receptor agonists fMLP (1 microM, IC50 18.4+/-1.8 and 31+/-1.8 microM), and C5a (0.1 microM, IC50 41.6+/-3.5 and 42+/-8.3 microM), and also inhibited elastase and beta-glucuronidase secretion (IC50 37.7+/-7 and 25.4+/-2.2 microM) and production of 5-lipoxygenase metabolites leukotriene B4 (LTB4), 6-trans-LTB4 and 12-trans-epi-LTB4 (IC50 48+/-7 microM) by PMN stimulated with the calcium ionophore A23187 (5 microM). 6. trans-Resveratrol significantly reduced the expression and activation of the beta2 integrin MAC-1 on PMN surface following stimulation, as revealed by FACS analysis of the binding of an anti-MAC-1 monoclonal antibody (MoAb) and of the CBRM1/5 MoAb, recognizing an activation-dependent epitope on MAC-1. Consistently, PMN homotypic aggregation and formation of mixed cell-conjugates between PMN and thrombin-stimulated fixed platelets in a dynamic system were also prevented by transresveratrol. 7. These results, indicating that trans-resveratrol interferes with the release of inflammatory mediators by activated PMN and down-regulates adhesion-dependent thrombogenic PMN functions, may provide some biological plausibility to the protective effect of red wine consumption against CHD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605577      PMCID: PMC1565338          DOI: 10.1038/sj.bjp.0701784

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets.

Authors:  Y Dobrydneva; R L Williams; P F Blackmore
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Wine, spirits and the lung: good, bad or indifferent?

Authors:  Stephan L Kamholz
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

Review 3.  Prevention of cardiovascular risk by moderate alcohol consumption: epidemiologic evidence and plausible mechanisms.

Authors:  Augusto Di Castelnuovo; Simona Costanzo; Maria Benedetta Donati; Licia Iacoviello; Giovanni de Gaetano
Journal:  Intern Emerg Med       Date:  2010-02-03       Impact factor: 3.397

4.  Longevity nutrients resveratrol, wines and grapes.

Authors:  Istvan Lekli; Diptarka Ray; Dipak K Das
Journal:  Genes Nutr       Date:  2009-09-04       Impact factor: 5.523

5.  Inhibition of cardiac voltage-gated sodium channels by grape polyphenols.

Authors:  C H R Wallace; I Baczkó; L Jones; M Fercho; P E Light
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

6.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

7.  Resveratrol inhibits nicotinic stimulation-evoked catecholamine release from the adrenal medulla.

Authors:  Seong-Chang Woo; Gwang-Moon Na; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

8.  Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy.

Authors:  Woo Taek Kim; Eok Soo Suh
Journal:  Korean J Ophthalmol       Date:  2010-04-06

Review 9.  Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

10.  Provinol inhibits catecholamine secretion from the rat adrenal medulla.

Authors:  Jung-Hee Lee; Yu-Seung Seo; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.